GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,053,000 | +71.7% | 64,791 | -8.6% | 0.01% | +83.3% |
| Q4 2020 | $8,183,000 | +32.8% | 70,900 | +12.0% | 0.01% | +20.0% |
| Q3 2020 | $6,162,000 | -18.4% | 63,300 | +2.9% | 0.01% | -28.6% |
| Q2 2020 | $7,547,000 | +40.6% | 61,500 | +0.3% | 0.01% | +16.7% |
| Q1 2020 | $5,368,000 | -19.7% | 61,300 | -4.1% | 0.01% | 0.0% |
| Q4 2019 | $6,681,000 | +5.2% | 63,900 | +15.8% | 0.01% | 0.0% |
| Q3 2019 | $6,350,000 | +12.0% | 55,200 | +67.8% | 0.01% | -14.3% |
| Q2 2019 | $5,672,000 | +1.1% | 32,900 | -1.2% | 0.01% | 0.0% |
| Q1 2019 | $5,613,000 | +70.5% | 33,300 | -1.5% | 0.01% | +40.0% |
| Q4 2018 | $3,292,000 | -48.6% | 33,800 | -8.9% | 0.01% | -37.5% |
| Q3 2018 | $6,409,000 | +15.4% | 37,100 | -6.8% | 0.01% | 0.0% |
| Q2 2018 | $5,554,000 | +3.3% | 39,800 | -16.6% | 0.01% | 0.0% |
| Q1 2018 | $5,374,000 | -18.6% | 47,700 | -4.6% | 0.01% | -11.1% |
| Q4 2017 | $6,601,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|